Companies that own Celyad S.A.
Invesco Asset Management Ltd.
267,202
2.24%
1,563
0.01%
03/29/2018
BNP Paribas Asset Management Belgium SA
114,942
0.96%
-1,983
0.03%
07/31/2018
Degroof Petercam Asset Management SA
93,773
0.79%
49,773
0.02%
12/31/2017
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden)
76,409
0.64%
-2,553
0.19%
08/31/2018
Dimensional Fund Advisors LP
57,583
0.48%
-698
0%
04/30/2018
AXA Investment Managers UK Ltd.
45,200
0.38%
45,200
0.01%
02/28/2018
La Banque Postale Asset Management SA
23,050
0.19%
0
0%
06/29/2018
KBL European Private Bankers SA
16,100
0.14%
0
0.01%
07/31/2018
AXA Investment Managers (Paris) SA
12,000
0.1%
12,000
0%
12/31/2017
Aviva Investors Global Services Ltd.
10,670
0.09%
0
0%
10/15/2017
| Address |
Axis Business Park
Mont-Saint-Guibert WA 1435
Belgium
|
|
Employees
|
- |
| Website |
http://www.celyad.com |
| Updated |
07/08/2019 |
| Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium. |
